Skip to Main Content

Print | Bookmark | Email | Font Size: + |

April 12, 2024

April 2024 HCPCS Updates – New, Revised, and Discontinued HCPCS Codes and Modifiers – Revised

The following information is based on the April 2024 Healthcare Common Procedure Coding System (HCPCS) file. These updates were effective April 1, 2024.

Note: That the appearance of a HCPCS code does not mean it is covered by the DME MAC.

This list shows HCPCS codes that will be effective April 1, 2024.

A4271 Integrated lancing and blood sample testing cartridges for home blood glucose monitor, per month
A4593 Neuromodulation stimulator system, adjunct to rehabilitation therapy regime
A4594 Neuromodulation stimulator system, adjunct to rehabilitation therapy regime, mouthpiece each
E0152 Walker, battery powered, wheeled, folding, adjustable or fixed height
E0468 Home ventilator, dual-function respiratory device, also performs additional function of cough stimulation, includes all accessories, components and supplies for all functions
E0736 Transcutaneous tibial nerve stimulator
E0738 Upper extremity rehabilitation system providing active assistance to facilitate muscle re-education, include microprocessor, all components and accessories
E0739 Rehab system with interactive interface providing active assistance in rehabilitation therapy, includes all components and accessories, motors, microprocessors, sensors
E2104 Home blood glucose monitor for use with integrated lancing/blood sample testing cartridge
E2298 Complex rehabilitative power wheelchair accessory, power seat elevation system, any type
J0177 Injection, aflibercept hd, 1 mg
J0209 Injection, sodium thiosulfate (hope), 100 mg
J0577 Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy
J0578 Injection, buprenorphine extended-release (brixadi), greater than 7 days and up to 28 days of therapy
J0589 Injection, daxibotulinumtoxina-lanm, 1 unit
J0650 Injection, levothyroxine sodium, not otherwise specified, 10 mcg
J0651 Injection, levothyroxine sodium (fresenius kabi) not therapeutically equivalent to j0650, 10 mcg
J0652 Injection, levothyroxine sodium (hikma) not therapeutically equivalent to j0650, 10 mcg
J1010 Injection, methylprednisolone acetate, 1 mg
J1202 Miglustat, oral, 65 mg
J1203 Injection, cipaglucosidase alfa-atga, 5 mg
J1323 Injection, elranatamab-bcmm, 1 mg
J1434 Injection, fosaprepitant (focinvez), 1 mg
J2277 Injection, motixafortide, 0.25 mg
J2782 Injection, avacincaptad pegol, 0.1 mg
J2801 Injection, risperidone (rykindo), 0.5 mg
J2919 Injection, methylprednisolone sodium succinate, 5 mg
J3055 Injection, talquetamab-tgvs, 0.25 mg
J3424 Injection, hydroxocobalamin, intravenous, 25 mg
J7165 Injection, prothrombin complex concentrate, human-lans, per i.u. of factor ix activity
J7354 Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)
J9073 Injection, cyclophosphamide (ingenus), 5 mg
J9074 Injection, cyclophosphamide (sandoz), 5 mg
J9075 Injection, cyclophosphamide, not otherwise specified, 5 mg
J9248 Injection, melphalan (hepzato) 1 mg
J9249 Injection, melphalan (apotex), 1 mg
J9255 Injection, methotrexate (Accord), not therapeutically equivalent to J9260, 50 mg
J9376 Injection, pozelimab-bbfg, 1 mg
K1037 Docking station for use with oral device/appliance used to reduce upper airway collapsibility
L1320 Thoracic, pectus carinatum orthosis, sternal compression, rigid circumferential frame with anterior and posterior rigid pads, custom fabricated
L5783 Addition to lower extremity, user adjustable, mechanical, residual limb volume management system
L5841 Addition, endoskeletal knee-shin system, polycentric, pneumatic swing, and stance phase control
Q5133 Injection, tocilizumab-bavi (tofidence), biosimilar, 1 mg
Q5134 Injection, natalizumab-sztn (tyruko), biosimilar, 1 mg

The following HCPCS codes have description/verbiage changes that will be effective April 1, 2024.

E2001 Suction pump, home model, portable or stationary, electric, any type, for use with external urine and/or fecal management system
J0208 Injection, sodium thiosulfate (pedmark), 100 mg
J0612 Injection, calcium gluconate, not otherwise specified, 10 mg
J0613 Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg
J3380 Injection, vedolizumab, intravenous, 1 mg
J3425 Injection, hydroxocobalamin, intramuscular, 10 mcg
J7516 Injection, cyclosporine, 250 mg
J9029 Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose
J9260 Injection, methotrexate sodium, 50 mg
J9071 Injection, cyclophosphamide (auromedics), 5 mg
J9072 Injection, cyclophosphamide (dr. reddy's), 5 mg

The following listing contains discontinued HCPCS codes, along with the cross-walked HCPCS codes (if applicable). Please note, not all discontinued HCPCS codes will have a cross-walked HCPCS code. 

E2300 03/31/2024  
J0576 03/31/2024  
J1020 03/31/2024  
J1030 03/31/2024  
J1040 03/31/2024  
J1840 03/31/2024  
J1850 03/31/2024  
J2920 03/31/2024  
J2930 03/31/2024  
J9070 03/31/2024  
J9250 03/31/2024  

Publication History

March 8, 2024 Originally Published
April 12, 2024 Added HCPCS codes J0577, J0578, J1010, J1202, J2919, J7354, J9073, J9074, J9075, J9248, J9249, J9255


26 Century Blvd Ste ST610, Nashville, TN 37214-3685 © CGS Administrators, LLC. All Rights Reserved